These are the top stories written by Business Insider's healthcare team for the week ending February 19.
7
Harris told "Axios on HBO" that the Trump administration left the country with no vaccine stockpile and no national strategy.
10
"Neutralizing antibodies were not detected in serum and IgG responses were not detected in most subjects," Vaxart said in a press release.
8
Biden's team expected the US COVID-19 death toll to climb sharply, Dr. Rochelle Walensky said, but was "confident" it would meet its vaccine target.
8
The New York governor said bypassing the government's Operation Warp Speed would enable his state to reach herd immunity as soon as possible.
5
Dr. Anthony Fauci said AstraZeneca and Johnson & Johnson's vaccines, still in clinical trials, could be submitted for FDA approval within a week.
6
If the Covid vaccine push has proved anything, it’s that big government works.
4
A complicated set of guidelines regarding which Americans should get priority have stymied states' efforts to maximize the number of shots in arms.
3
Catch up on the most important updates from this week.
3
"This is a deception on a national scale.," Oregon Gov. Kate Brown tweeted Friday, criticizing the federal government's vaccine distribution plan.
8
The New York Department of Health warned of a "very limited" COVID-19 vaccine supply that has backed up appointments for more than three months.
5
Dr. David Kessler has worked closely alongside President-elect Joe Biden as an advisor to his transition team on COVID-19.
6
While scamming has been prevalent since the coronavirus vaccine was authorized in December, the number of ads have continued to increase.
7
The new system is meant to get more shots in arms, but it could also punish states that lack the funding or resources to quickly administer doses.
3
Changing plans was always the plan, but it's unclear what will change before Jan. 20.
8
The practice isn't currently supported by adequate scientific evidence, the FDA warned, and "may ultimately be counterproductive to public health."
5
Drug industry analysts predict how 2021 will play out for Pfizer, Moderna, and the global market for COVID-19 mRNA coronavirus vaccines.
7
Distribution issues have sprung up across the nation, including some healthcare and frontline workers simply refusing to receive the vaccine.
7
After some leaders have suggested short-cuts to vaccinate more people quicker, the FDA has issued guidance that the good intentions could backfire.
6
Could cutting or delaying vaccine doses help—or make things worse?
6
More

Top